Clinical features of patients
| Case No | Age at diagnosis | ISG criteria | Additional features | Length of disease to diagnosis | Treatment required | HLA-B51 status |
|---|---|---|---|---|---|---|
| 1 | 45 | Y | Aneurysm | 2 | Prednisolone/azathioprine | Neg |
| 2 | 26 | N | Neurological | 3 | Anti-TB/prednisolone | ND |
| 3 | 31 | Y | Thrombosis | 0 | Prednisolone/azathioprine/tacrolimus/mycophenolate/cyclosporin | Neg |
| 4 | 20 | Y | – | 2 | Prednisolone/cyclosporin/mycophenolate | Neg |
| 5 | 35 | Y | Intestinal and neurological disease | 0 | Prednisolone/azathioprine | Neg |
| 6 | 30 | Y | – | 1 | Prednisolone/azathioprine | Neg |
| 7 | 34 | Y | Arthralgia | 10 | Azathioprine/prednisolone/colchicine | Neg |
| 8 | 32 | Y | – | 3 | Topical prednisolone | ND |